Editorial Board Members’ Collection Series: Bacterial Toxins, Recombinant and Native Toxins, as Therapeutic Agents
A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Bacterial Toxins".
Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 186
Special Issue Editors
Interests: botulinum toxins; muscle spasticity; movement disorders; rehabilitation; ultrasound
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce a new collection titled “Editorial Board Members’ Collection Series: Bacterial Toxins, Recombinant and Native Toxins, as Therapeutic Agents”, which will collect papers invited by the Editorial Board Members.
Bacterial toxins have been a topic of intense research and study for several decades, due to their ability to target specific cells and tissues in the body. These toxins have been shown to have therapeutic properties, and they have been used to treat a wide range of diseases including cancer, autoimmune disorders, and neurological conditions. There are two main types of bacterial toxins that are being researched and developed as therapeutic agents: recombinant toxins and native toxins. Recombinant toxins are engineered versions of bacterial toxins that have been modified to reduce their toxicity while retaining their therapeutic properties. They have been used to treat cancer and autoimmune diseases, among others, and work by binding to specific proteins on the surface of cells and killing them, thereby reducing the size of the affected tissue. Native toxins have been found to be effective against many types of cancer, as well as autoimmune and neurological disorders. They work by binding to specific proteins on the surface of cells and either killing them or altering their function.
Bacterial toxins represent a promising class of therapeutic agents that have been shown to be effective against a wide range of diseases. Despite the challenges associated with their use, the benefits of bacterial toxins as therapeutic agents are substantial and further research and development in this area is likely to lead to new and effective treatments for a wide range of conditions. The aim of this collection is to provide a venue for networking and communication between Toxins and scholars in the field of bacterial toxins as therapeutic agents. This collection will focus on bacterial toxins, specifically recombinant and native toxins as therapeutic agents. All papers will be published in an open access format following peer review.
Dr. Alessandro Picelli
Dr. Domenico Restivo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- recombinant toxins
- native toxins
- botulinum toxin
- binding
- mechanism of action
- neurological disorders
- cancer
